RhythmX AI, a new artificial intelligence (AI)-native health company offering a precision care platform to help doctors deliver hyper-personalised care to patients, has been launched.

Founded by healthcare leader Deepthi Bathina and chaired by AI entrepreneur Dr. Romesh Wadhwani, RhythmX AI secured an initial investment of $50m from private investment firm SAIGroup.

The precision care platform uses generative AI and predictive AI algorithms to provide patient-specific prescriptive actions and recommendations to doctors.

These insights can be explored through a user-friendly, generative AI-driven, natural language interface, supported by AI-native co-pilots.

SAIGroup founder and CEO Dr. Romesh Wadhwani said: “It's time to apply AI to the massive challenges doctors and hospital systems face in providing the best treatments for patients.

“SAIGroup's strategy of combining deep domain expertise with advanced AI has a successful track record with SymphonyAI and ConcertAI and will do the same with RhythmX AI.

“The rapidly growing team at RhythmX AI has the right assets, data, AI expertise, and the right capital and leadership to solve these barriers.”

RhythmX AI will use data from SAIGroup, such as information about 300 million patients, 4.4 billion annual claims, and 1.8 million healthcare professionals at 300,000 facilities.

They plan to add more data sources as they expand.

Backed by SAIGroup, which brings with it the knowledge and resources of portfolio companies SymphonyAI and ConcertAI, RhythmX AI is set to leverage the Eureka AI platform to develop its Precision Care Platform.

EurekaAI is a cloud-based artificial intelligence platform that helps organisations across various sectors, including life sciences, healthcare, and finance.